MedTrace Logo

Investigating the Effect of Vortioxetine in Adult ADHD Patients

NCT02327013 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 227

Last updated 2018-03-07

Study results available
· View outcomes & findings →

Summary

The purpose is to determine the effect of vortioxetine treatment on ADHD symptoms in adult patients with ADHD in a 12 weeks study.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

DRUG

vortioxetine 10 mg tablet

Oral tablets, once daily

DRUG

vortioxetine 20 mg tablet

Oral tablets, once daily

OTHER

Placebo tablet

Oral tablets, once daily

Sponsors & Collaborators

  • H. Lundbeck A/S

    lead INDUSTRY

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02327013 on ClinicalTrials.gov